The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats

Psychopharmacology

Volumn 152, Issue 1, 2000, Pages 93-104

  Cook, Charles D ^a   Barrett, Andrew C ^a   Syvanthong, Chockeo ^a   Picker, Mitchell J ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

7 OH DPAT; Antinociception; Opioid physical dependence; Opioid tolerance; Rat

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE TIME EFFECT RELATION; DRUG WITHDRAWAL; LOCOMOTION; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMAL; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; MALE; MORPHINE; MORPHINE DEPENDENCE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, LONG-EVANS; RECEPTORS, DOPAMINE D2; SUBSTANCE WITHDRAWAL SYNDROME; SUPPORT, U.S. GOV'T, P.H.S.; TETRAHYDRONAPHTHALENES; TIME FACTORS;

EID: 0033803130     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000520     Document Type: Article

References (67)

1. Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state
2. The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats
3. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior
4. Effects of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa opioid receptor agonist, in the mouse
5. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective m or d opioid agonists in mice
6. Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists
7. Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice
8. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: Comparison with dopamine D2 receptor mRNA
9. Lack of discrimination by agonists for D2 and D3 dopamine receptors
10. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine
11. Activation of heterologously expressed D3 dopamine receptors: Comparison with D2 dopamine receptors
12. Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons: Importance of training dose and attenuation by the D3 agonist (+)-7-OH-DPAT
13. Selective attenuation of the antinociceptive effects of mu opioid by the putative dopamine D3 agonist 7-OH-DPAT
14. Modulatory effects of dopamine D3/2 agonists on kappa opioid-induced antinociception and diuresis in the rat
15. Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other 'D-2 like' agonists
16. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference
17. Dopaminergic mechanisms of opiate actions in brain
18. The role of dopamine in the expression of morphine withdrawal
19. 2+ channel expression
20. The effects of 6-hydroxydopamine on morphine tolerance and physical dependence
21. Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions
22. Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum
23. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists
24. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome
25. Efficacy and kinetics of opioid action on acutely dissociated neurons
26. Molecular mechanisms of opioid receptor signal transduction
27. κ- And μ-opioid inhibition of N-type calcium currents is attenuated by 4β-phorbol 12-myristate 13-acetate and protein kinase C in rat dorsal root ganglion neurons
28. Dopamine D-1 and D-2 receptor antagonists potentiate analgesic and motor effects of morphine
29. 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist
30. Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells
31. 3 dopamine receptors stably transfected into NG108-G115 cells couple to voltage-dependent potassium current via distinct G protein mechanisms
32. 35S]binding
33. Anatomy of CNS opioid receptors
34. Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats
35. Chronically administered morphine increases dopamine receptor sensitivity in mice
36. Repeated 7-OH-DPAT treatments: Behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine
37. Attenuation of the discriminative stimulus strength of morphine by haloperidol
38. The effect of dopaminergic modifiers on morphine-induced analgesia and respiratory depression
39. The human μ opioid receptor: Modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C
40. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297. I. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy
41. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: A comparative characterization with novel ligands at D3 versus D2 receptors
42. Dopamine receptor subtypes and formalin test analgesia
43. 35]thio-triphosphate binding and antibody study
44. Increased analgesic potency of mu agonists after continuous naloxone infusion in rats
45. + channels (GIRK1) in a Xenopus oocyte expression system: Selective antagonism by L-741,626 and L-745-870 respectively
46. Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effects of morphine in rats
47. Functional expression and characterization of human D2 and D3 dopamine receptors
48. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907
49. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: A useful model for the study of tolerance at mu opioid receptors
50. Evidence for the behavioral supersensitivity of dopamine D2 receptors without receptor up-regulation in morphine-abstinent rats
51. Neurotransmitter receptors. V. Opiate receptors
52. 3H)-spiroperidol binding
53. Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor
54. Evaluation of selective actions of dopamine D-1 and D-2 receptor agonists and antagonists on opioid antinociception
55. A functional test identifies dopamine agonists selective for D3 versus D2 receptors
56. Opioid tolerance and dependence in light of the multiplicity of opioid receptors
57. Examination of the neurochemical substrates mediating the motivational effects of opioids: Role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors
58. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons
59. Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine administration
60. The D3-receptor agonist (+)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice
61. Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines
62. Chronic opioid treatment may uncouple opioid receptors and G-proteins: Evidence from radiation inactivation analysis
63. Attenuation and reversal of morphine tolerance by the competitive N-methyl-d-aspartate receptor antagonist, LY274614
64. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801
65. Comparison of the ligand binding and signaling properties of human dopamine D2 and D3 receptors in Chinese hamster ovary cells
66. D2, D3 and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes